| Q37249726 | 851 resected cystic tumors of the pancreas: a 33-year experience at the Massachusetts General Hospital |
| Q33443121 | A blinded assessment of video quality in wearable technology for telementoring in open surgery: the Google Glass experience |
| Q30724746 | A combination of molecular markers and clinical features improve the classification of pancreatic cysts |
| Q40442416 | A multicenter randomized controlled trial comparing pancreatic leaks after TissueLink versus SEAMGUARD after distal pancreatectomy (PLATS) NCT01051856. |
| Q91967661 | A multimodality test to guide the management of patients with a pancreatic cyst |
| Q36685241 | A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine followed by early surgery for resectable pancreatic ductal adenocarcinoma |
| Q37213647 | Assessment of pancreatic tumor resectability with multidetector computed tomography: semiautomated console-generated images versus dedicated workstation-generated images |
| Q37328886 | Autoimmune pancreatitis: disease evolution, staging, response assessment, and CT features that predict response to corticosteroid therapy |
| Q35670102 | Beta cell transdifferentiation does not contribute to preneoplastic/metaplastic ductal lesions of the pancreas by genetic lineage tracing in vivo |
| Q36881630 | Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection |
| Q37803171 | Cholesterol crystal embolization presenting as either solid or cystic pancreatic lesion |
| Q35988678 | Circulating Epithelial Cells in Patients with Pancreatic Lesions: Clinical and Pathologic Findings |
| Q34275728 | Consensus statement on the pathology of IgG4-related disease |
| Q37249696 | Current trends in pancreatic cystic neoplasms |
| Q37172565 | Cystic pancreatic endocrine neoplasms: a distinct tumor type? |
| Q36311735 | Cystic pancreatic lesions: a simple imaging-based classification system for guiding management |
| Q37988375 | Cystic papillary pattern in pancreatic ductal adenocarcinoma: a heretofore undescribed morphologic pattern that mimics intraductal papillary mucinous carcinoma |
| Q37279909 | Cytology adds value to imaging studies for risk assessment of malignancy in pancreatic mucinous cysts |
| Q37063952 | Debridement and closed packing for sterile or infected necrotizing pancreatitis: insights into indications and outcomes in 167 patients |
| Q38583952 | Decreased inflammation and improved survival with recombinant human activated protein C treatment in experimental acute pancreatitis |
| Q38217067 | Delaying chemoradiation until after completion of adjuvant chemotherapy for pancreatic cancer may not impact local control |
| Q39025112 | Development and Validation of a Multi-Institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium |
| Q38557712 | Diagnosis and Management of Pancreatic Cystic Neoplasms |
| Q38076383 | Diagnosis and management of cystic pancreatic lesions |
| Q39826267 | Direct medical costs of acute pancreatitis hospitalizations in the United States |
| Q37320987 | Distal biliary malignancy |
| Q37252193 | Distal pancreatectomy with splenic preservation revisited |
| Q35102202 | Does the mechanism of lymph node invasion affect survival in patients with pancreatic ductal adenocarcinoma? |
| Q37724138 | Enhanced primary tumor delineation in pancreatic adenocarcinoma using ultrasmall super paramagnetic iron oxide nanoparticle-ferumoxytol: an initial experience with histopathologic correlation |
| Q24605921 | Evolution of the Whipple procedure at the Massachusetts General Hospital |
| Q36793415 | Evolving patterns in the detection and outcomes of pancreatic neuroendocrine neoplasms: the Massachusetts General Hospital experience from 1977 to 2005. |
| Q24622390 | FOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experience |
| Q37959785 | Gallbladder lesions identified on ultrasound. Lessons from the last 10 years |
| Q35033667 | Giant lipoma of the pancreas: case report and review of lipomatous lesions of the pancreas |
| Q37643001 | Global genomic analysis of intraductal papillary mucinous neoplasms of the pancreas reveals significant molecular differences compared to ductal adenocarcinoma |
| Q94947192 | Guidelines on the histopathology of chronic pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the International Association of Pancreatology, the American P |
| Q38242457 | Hepatic hydatid cyst: a rare cause of recurrent pancreatitis |
| Q33226273 | Histopathological diagnosis of pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms: interobserver agreement |
| Q38224748 | IPMN involving the main pancreatic duct: biology, epidemiology, and long-term outcomes following resection |
| Q37020114 | Identification of a novel kindred with familial pancreatitis and pancreatic cancer |
| Q38819132 | Imaging of pancreatic cystic lesions with confocal laser endomicroscopy: an ex vivo pilot study |
| Q37721605 | Implications and cost of pancreatic leak following distal pancreatic resection |
| Q37249730 | Implications and management of pancreatic fistulas following pancreaticoduodenectomy: the Massachusetts General Hospital experience |
| Q36943954 | Implications of incidentally discovered, nonfunctioning pancreatic endocrine tumors: short-term and long-term patient outcomes |
| Q37249621 | Improved contemporary surgical management of insulinomas: a 25-year experience at the Massachusetts General Hospital |
| Q36478584 | In vivo lineage tracing defines the role of acinar-to-ductal transdifferentiation in inflammatory ductal metaplasia |
| Q35494053 | Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients |
| Q35546089 | Incidental pancreatic cysts: do we really know what we are watching? |
| Q38017783 | International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas |
| Q36331064 | International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas |
| Q37893875 | Interventional radiology in the management of abdominal collections after distal pancreatectomy: a retrospective review |
| Q39938179 | Intra-pancreatic Distal Bile Duct Carcinoma is Morphologically, Genetically, and Clinically Distinct from Pancreatic Ductal Adenocarcinoma |
| Q26796495 | Intraductal Papillary Mucinous Adenocarcinoma of the Pancreas: Clinical Outcomes, Prognostic Factors, and the Role of Adjuvant Therapy |
| Q30240964 | Intraductal Papillary Mucinous Neoplasm of the Pancreas |
| Q38685843 | Intraductal Papillary Mucinous Neoplasm of the Pancreas: Current State of the Art and Ongoing Controversies |
| Q35768008 | Intraductal papillary mucinous adenocarcinoma of the pancreas: clinical outcomes, prognostic factors, and the role of adjuvant therapy |
| Q36377469 | Intraductal papillary mucinous neoplasm of pancreas: multi-detector row CT with 2D curved reformations--correlation with MRCP. |
| Q38540611 | Intraductal papillary mucinous neoplasms |
| Q37249723 | Intraductal papillary mucinous neoplasms: does a family history of pancreatic cancer matter? |
| Q35102376 | Invasive intraductal papillary mucinous carcinomas of the pancreas: predictors of survival and the role of lymph node ratio |
| Q38257929 | Is it safe to follow side branch IPMNs? |
| Q38664002 | Long-Term Risk of Pancreatic Malignancy in Patients with Branch Duct Intraductal Papillary Mucinous Neoplasm in A Referral Center |
| Q38736214 | Loss of Trefoil Factor 2 From Pancreatic Duct Glands Promotes Formation of Intraductal Papillary Mucinous Neoplasms in Mice |
| Q33948175 | Lymphoepithelial cysts and cystic lymphangiomas: Under-recognized benign cystic lesions of the pancreas |
| Q37156920 | Management of intraductal papillary mucinous neoplasms |
| Q91578433 | Management of the pancreatic transection plane after left (distal) pancreatectomy: Expert consensus guidelines by the International Study Group of Pancreatic Surgery (ISGPS) |
| Q40526083 | Membrane-bound ICAM-1 is upregulated by trypsin and contributes to leukocyte migration in acute pancreatitis |
| Q35102388 | Metastatic Tumors in the Pancreas in the Modern Era |
| Q37016439 | Minutes of the business meeting of the American Pancreatic Association, Friday, November 2, 2012, Miami, Florida |
| Q35102198 | Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics |
| Q37249734 | Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients |
| Q36978995 | Mucinous cystic neoplasms |
| Q38682495 | Multi-Institutional Validation Study of Pancreatic Cyst Fluid Protein Analysis for Prediction of High-Risk Intraductal Papillary Mucinous Neoplasms of the Pancreas |
| Q38830982 | Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma |
| Q37249638 | N0/N1, PNL, or LNR? The effect of lymph node number on accurate survival prediction in pancreatic ductal adenocarcinoma |
| Q33269950 | National study of United States emergency department visits for acute pancreatitis, 1993-2003. |
| Q34909909 | Novel xenograft and cell line derived from an invasive intraductal papillary mucinous neoplasm of the pancreas give new insights into molecular mechanisms |
| Q38404533 | Oncocytic-type intraductal papillary mucinous neoplasms: a unique malignant pancreatic tumor with good long-term prognosis |
| Q37864189 | Open pancreatic necrosectomy: indications in the minimally invasive era. |
| Q37607501 | Outcomes and tolerability of chemoradiation therapy for pancreatic cancer patients aged 75 years or older |
| Q37779912 | Pancreatic cancer tumor size on CT scan versus pathologic specimen: implications for radiation treatment planning |
| Q34341483 | Pancreatic cystic neoplasms: management and unanswered questions |
| Q36378663 | Pancreatic cysts 3 cm or smaller: how aggressive should treatment be? |
| Q37665389 | Pancreatic cysts: preoperative diagnosis and clinical management |
| Q37249748 | Pancreatic duct glands are distinct ductal compartments that react to chronic injury and mediate Shh-induced metaplasia |
| Q34639984 | Pancreatic ductal adenocarcinoma: long-term survival does not equal cure |
| Q37243926 | Pancreatic fistula rates after 462 distal pancreatectomies: staplers do not decrease fistula rates |
| Q38025291 | Pancreatic surgery for adenocarcinoma |
| Q36055277 | Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting |
| Q38385287 | Patterns of Recurrence After Resection of IPMN: Who, When, and How? |
| Q30416761 | Plectin-1 is a biomarker of malignant pancreatic intraductal papillary mucinous neoplasms |
| Q38907944 | Post-Whipple imaging in patients with pancreatic ductal adenocarcinoma: association with overall survival: a multivariate analysis |
| Q40201555 | Potential impact of a volume pledge on spatial access: A population-level analysis of patients undergoing pancreatectomy |
| Q40832645 | Preoperative biliary drainage does not increase major complications in pancreaticoduodenectomy: a large single center experience from the Massachusetts General Hospital |
| Q38016795 | Preoperative evaluation and management of the pancreatic head mass |
| Q37249683 | Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes |
| Q35543059 | Pylorus‐preserving Pancreaticoduodenectomy in the Treatment of Chronic Pancreatitis |
| Q38534888 | Quality assessment of the guidelines on cystic neoplasms of the pancreas |
| Q37249715 | Quality of life in pancreatic cancer: analysis by stage and treatment |
| Q38674441 | Reappraisal of Staging Laparoscopy for Patients with Pancreatic Adenocarcinoma: A Contemporary Analysis of 1001 Patients |
| Q37117829 | Recurrence and Survival After Resection of Small Intraductal Papillary Mucinous Neoplasm-associated Carcinomas (≤20-mm Invasive Component): A Multi-institutional Analysis |
| Q39452846 | Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas |
| Q38769396 | Risk of pancreatic malignancy and mortality in branch-duct IPMNs undergoing surveillance: A systematic review and meta-analysis |
| Q36559908 | Selective and reversible suppression of intestinal stem cell differentiation by pharmacological inhibition of BET bromodomains |
| Q38074119 | Short-term and long-term outcomes for patients with autoimmune pancreatitis after pancreatectomy: a multi-institutional study |
| Q39120780 | Single-stage cholecystectomy at the time of pancreatic necrosectomy is safe and prevents future biliary complications: a 20-year single institutional experience with 217 consecutive patients |
| Q30410852 | Standardized terminology and nomenclature for pancreatobiliary cytology: The Papanicolaou Society of Cytopathology Guidelines |
| Q90405104 | Standards for reporting on surgery for chronic pancreatitis: a report from the International Study Group for Pancreatic Surgery (ISGPS) |
| Q35076197 | Surgery of cystic neoplasms |
| Q35673204 | Survival in ampullary cancer: potential role of different KRAS mutations |
| Q39063628 | The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After |
| Q35864160 | The proteome of postsurgical pancreatic juice |
| Q36798760 | The value of KRAS mutation testing with CEA for the diagnosis of pancreatic mucinous cysts |
| Q38403058 | Tolerability and Long-term Outcomes of Dose-Painted Neoadjuvant Chemoradiation to Regions of Vessel Involvement in Borderline or Locally Advanced Pancreatic Cancer |
| Q28191550 | Troponin I peptide (Glu94-Leu123), a cartilage-derived angiogenesis inhibitor: in vitro and in vivo effects on human endothelial cells and on pancreatic cancer |
| Q37851809 | Twenty-three years of the Warshaw operation for distal pancreatectomy with preservation of the spleen |
| Q35493880 | Updated long-term outcomes and prognostic factors for patients with unresectable locally advanced pancreatic cancer treated with intraoperative radiotherapy at the Massachusetts General Hospital, 1978 to 2010 |